Tags

Type your tag names separated by a space and hit enter

Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia.
Virulence. 2014 Aug 15; 5(6):650-4.V

Abstract

Coronaviruses have traditionally been associated with mild upper respiratory tract infections throughout the world. In the fall of 2002, a new coronavirus emerged in in Asia causing severe viral pneumonia, i.e., severe acute respiratory syndrome (SARS). Nearly a decade following the SARS epidemic, a new coronavirus causing severe viral pneumonia has emerged, i.e., middle east respiratory syndrome (MERS). Since the initial case of MERS-CoV occurred in June of 2012 in Saudi Arabia there have been 688 confirmed cases and 282 deaths in 20 countries. Although both SARS and MERS are caused by coronaviruses, SARS was characterized by efficient human transmission and relatively low mortality rate. In contrast, MERS is relatively inefficiently transmitted to humans but has a high mortality rate. Given the potential overlap in presentation and manifestation, it is important to understand the clinical and epidemiologic differences between MERS, SARS and influenza.

Authors+Show Affiliations

Division of Infectious Disease; Rhode Island Hospital and The Miriam Hospital; Providence, RI USA; Division of Infectious Disease; Brown University Alpert School of Medicine; Providence, RI USA.Division of Infectious Disease; Brown University Alpert School of Medicine; Providence, RI USA; Division of Infectious Disease; Memorial Hospital; Pawtucket, RI USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25089913

Citation

Cunha, Cheston B., and Steven M. Opal. "Middle East Respiratory Syndrome (MERS): a New Zoonotic Viral Pneumonia." Virulence, vol. 5, no. 6, 2014, pp. 650-4.
Cunha CB, Opal SM. Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia. Virulence. 2014;5(6):650-4.
Cunha, C. B., & Opal, S. M. (2014). Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia. Virulence, 5(6), 650-4. https://doi.org/10.4161/viru.32077
Cunha CB, Opal SM. Middle East Respiratory Syndrome (MERS): a New Zoonotic Viral Pneumonia. Virulence. 2014 Aug 15;5(6):650-4. PubMed PMID: 25089913.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia. AU - Cunha,Cheston B, AU - Opal,Steven M, Y1 - 2014/08/04/ PY - 2014/8/5/entrez PY - 2014/8/5/pubmed PY - 2015/3/31/medline KW - MERS KW - Middle Eastern respiratory syndrome KW - coronavirus KW - emerging pathogens SP - 650 EP - 4 JF - Virulence JO - Virulence VL - 5 IS - 6 N2 - Coronaviruses have traditionally been associated with mild upper respiratory tract infections throughout the world. In the fall of 2002, a new coronavirus emerged in in Asia causing severe viral pneumonia, i.e., severe acute respiratory syndrome (SARS). Nearly a decade following the SARS epidemic, a new coronavirus causing severe viral pneumonia has emerged, i.e., middle east respiratory syndrome (MERS). Since the initial case of MERS-CoV occurred in June of 2012 in Saudi Arabia there have been 688 confirmed cases and 282 deaths in 20 countries. Although both SARS and MERS are caused by coronaviruses, SARS was characterized by efficient human transmission and relatively low mortality rate. In contrast, MERS is relatively inefficiently transmitted to humans but has a high mortality rate. Given the potential overlap in presentation and manifestation, it is important to understand the clinical and epidemiologic differences between MERS, SARS and influenza. SN - 2150-5608 UR - https://www.unboundmedicine.com/medline/citation/25089913/Middle_East_respiratory_syndrome__MERS_:_a_new_zoonotic_viral_pneumonia_ L2 - https://www.tandfonline.com/doi/full/10.4161/viru.32077 DB - PRIME DP - Unbound Medicine ER -